Detalhe da pesquisa
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322232
2.
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Nature
; 600(7890): 727-730, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912120
3.
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
N Engl J Med
; 388(18): 1657-1667, 2023 May 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37133585
4.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
N Engl J Med
; 386(5): 449-462, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108470
5.
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Lancet Oncol
; 25(2): 212-224, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134948
6.
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Lancet
; 402(10418): 2197-2208, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871604
7.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer
; 27(2): 375-386, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281295
8.
Real-world clinical scenarios during introduction of trastuzumab biosimilar for HER2-positive breast cancer in the European Union.
Future Oncol
; 20(13): 821-832, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305004
9.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 24(5): 483-495, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37080222
10.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(11): 1181-1195, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875143
11.
Safety and efficacy of trifluridine/tipiracil in previously treated metastatic colorectal cancer: final results from the phase IIIb single-arm PRECONNECT study by duration of therapy.
BMC Cancer
; 23(1): 94, 2023 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707808
12.
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer.
Future Oncol
; 19(37): 2445-2452, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37701986
13.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919706
14.
Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 23(1): 77-90, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34914889
15.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102137
16.
Long-term observation of gastric patients with positive immunocytochemistry of peritoneal washing.
Neoplasma
; 69(1): 216-223, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34881624
17.
Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial.
Neoplasma
; 69(6): 1445-1450, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36353936
18.
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Br J Cancer
; 125(7): 911-919, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34426663
19.
High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.
Mol Cell Proteomics
; 18(4): 642-656, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630936
20.
Neoadjuvant chemotherapy with or without oxaliplatin after short-course radiotherapy in high-risk rectal cancer: A subgroup analysis from a prospective study.
Rep Pract Oncol Radiother
; 25(6): 1017-1022, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33390858